Sentiment Trading

Vaxil Bio Ltd. is a biotechnology company advancing immunotherapy development for cancer and infectious diseases through innovative neoantigen-like peptide products and antibodies.

Vaxil Bio Ltd. faces uncertainty and stagnation, with a failed reverse takeover and stagnant finances casting doubt on its future prospects in the biotech sector.